Ján Murín

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

Paul M. Ridker, James H. Revkin, Pierre Amarenco et al. · New England Journal of Medicine · 2017 · 630 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Distribution and Risk Profile of Paroxysmal, Persistent, and Permanent Atrial Fibrillation in Routine Clinical Practice

Chern‐En Chiang, Lisa Naditch‐Brûlé, Ján Murín et al. · Circulation Arrhythmia and Electrophysiology · 2012 · 326 citations

Medicine, Cardiology, Internal Medicine +15

Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure

Miroslava Valentová, Stephan von Haehling, Juergen Bauditz et al. · European Heart Journal · 2016 · 223 citations

Medicine, Cardiology, Clinical Nutrition +14

Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry

Philippe Gabríel Steg, Samir Alam, Chern‐En Chiang et al. · Heart · 2011 · 137 citations

Medicine, Cardiology, Internal Medicine +13

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17